GORINI, ANTONELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.477
EU - Europa 1.849
AS - Asia 1.355
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
SA - Sud America 2
OC - Oceania 1
Totale 5.690
Nazione #
US - Stati Uniti d'America 2.468
CN - Cina 1.336
IE - Irlanda 540
UA - Ucraina 393
FI - Finlandia 325
DE - Germania 212
IT - Italia 106
FR - Francia 86
GB - Regno Unito 81
SE - Svezia 74
BE - Belgio 14
CA - Canada 9
NL - Olanda 8
IN - India 6
RU - Federazione Russa 6
SG - Singapore 5
JP - Giappone 4
EU - Europa 3
HK - Hong Kong 3
LV - Lettonia 2
PE - Perù 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
GR - Grecia 1
MA - Marocco 1
MU - Mauritius 1
MY - Malesia 1
NZ - Nuova Zelanda 1
Totale 5.690
Città #
Chandler 540
Dublin 540
Jacksonville 526
Nanjing 413
Ashburn 185
Nanchang 164
Princeton 139
Hebei 126
Lawrence 121
Shenyang 113
Beijing 107
Medford 103
Wilmington 102
Changsha 96
Helsinki 94
Tianjin 82
Jiaxing 80
Ann Arbor 71
Hangzhou 63
Boardman 62
Milan 35
Verona 31
Woodbridge 27
Pavia 24
Norwalk 21
Shanghai 15
Brussels 14
Washington 13
Fairfield 11
New York 10
Ningbo 9
Auburn Hills 8
Toronto 7
Zhengzhou 7
Jinan 6
Kunming 6
Orange 6
Seattle 6
Taizhou 6
Dearborn 5
Los Angeles 5
Changchun 4
Des Moines 4
Falls Church 4
Guangzhou 4
Singapore 4
Berlin 3
Houston 3
Ichibancho 3
Lanzhou 3
Parma 3
Walnut 3
Amsterdam 2
Carpi 2
Chicago 2
Houlbec-Cocherel 2
Hyderabad 2
Iquitos 2
Kemerovo 2
Novokuznetsk 2
San Antonio 2
Tappahannock 2
Almere Stad 1
Athens 1
Bangalore 1
Bari 1
Borås 1
Bovisio Masciago 1
Cornaredo 1
Corteolona 1
Falkenstein 1
Fuzhou 1
Haikou 1
Jinhua 1
Lubbock 1
Marlborough 1
Miami 1
Montreal 1
Mykolayiv 1
Ottawa 1
Phoenix 1
Piscataway 1
Rabat 1
Redwood City 1
Santa Clara 1
Stanton 1
Tokyo 1
Wellington 1
Totale 4.083
Nome #
Energy metabolism of lymphocytes from acute stroke patients 78
Principi di Farmacologia Generale 78
Effects of cerebral ischemia and postischemic recovery during aging on mitochondrial energy metabolism: an in vivo model for experimental therapy 76
ATPases of synaptic plasma membranes and vesicles from rat cerebral cortex during aging and hypoxia 75
Action of some antidepressants on mitochondrial energy metabolism of rat cerebral cortex 75
Age-related alterations of skeletal muscle metabolism by intermittent hypoxia and TRH-analogue treatment 74
Age-related alterations by chronic intermittent hypoxia on cerebral synaptosomal ATPase activities 73
Is the Mg(2+)-ATP-dependent proton pumping activity of the synaptic vesicles a factor involved in the cerebral hypoxia? 69
Action of dihydroergocristine on enzyme activities related to energy transduction 69
Acetylcholinesterase activity of synaptic plasma membranes during ageing: effect of L-acetylcarnitine 68
L-acetylcarnitine and ATP-ases of synaptic plasma membranes of rat hippocampus: implications for Alzheimer’s Disease and Dementias Therapy. 68
Functional proteomics of energy-linked enzymes in lymphocytes after stroke. 67
Effect of CDP-Choline on age-dependent modifications of energy and glutamate-linked enzyme activities in synaptic and non-synaptic mitochondria from rat cerebral cortex. 66
Adaptation of skeletal muscle energy metabolism to repeated hypoxic-normoxic exposures and drug treatment 65
Cerebral ischemia and peripheral energy dysfunction in lymphocytes 64
Action of L-acetylcarnitine on different cerebral mitochondrial populations from hippocampus 63
Principi di Farmacologia Generale 63
Acetylcholine esterase sensitivity to chronic administration of diphenylhydantoin and effects on cerebral enzymatic activities related to energy metabolism 63
Effect of in vivo administration of naloxone on ATP-ase's enzyme systems of synaptic plasma membranes from rat cerebral cortex 61
ATP-ases of synaptic plasma membranes in striatum: enzymatic systems for synapses functionality by in vivo administration of L-acetylcarnitine in relation to Parkinson's disease 60
Effect of some antidepressants on mitochondrial metabolism of rat cerebral cortex 58
Metabolomics of energy-linked enzymes in lymphocytes from acute stroke patients 58
Cerebral ischemia and peripheral energy dysfunction in lymphocytes 58
ATPases of synaptic plasma membranes from hippocampus after ischemia and recovery during ageing 56
Superoxide dismutase and cytochrome oxidase activities in light and heavy synaptic mitochondria from rat cerebral cortex during aging 56
Affective disorders, antidepressant drugs and brain metabolism 56
ATPases enzyme activities during ageing in different types of somatic and synaptic plasma membranes from rat frontal cerebral cortex 55
Action of L-acetylcarnitine on different cerebral mitochondrial populations from hippocampus and striatum during aging 55
Rat cortex synaptic and nonsynaptic mitochondria: enzymatic characterization and pharmacological effects of naftidrofuryl 55
Pharmacotherapy and prevention of vascular dementia 55
Cerebral ischemia and postischemic recovery during aging: metabolomics of Krebs’ cycle , glutamate and related amino acids enzyme activities as a functional approach for responsiveness of ischemic tissue. 55
Modifications by hypoxia and drug treatment of cerebral ATPase plasticity 54
Effect of ageing and ischemia on enzymatic activities linked to Krebs' cycle, electron transfer chain, glutamate and aminoacids metabolism of free and intrasynaptic mitochondria of cerebral cortex 54
Effect of in vivo L-acetylcarnitine administration on ATP-ases enzyme systems of synaptic plasma membranes from rat cerebral cortex 54
Principi di Farmacologia Generale 54
Enzyme activities in perikaryal and synaptic mitochondrial fractions from rat hippocampus during development 53
Energy metabolism of cerebral mitochondria during aging, ischemia and post-ischemic recovery assessed by functional proteomics of enzymes 53
Action of piracetam and clonidine on different mitochondrial populations from hippocampus 53
Synaptic and non-synaptic mitochondria from rat cerebral cortex. Characterization and effect of pharmacological treatment on some enzyme activities related to energy transduction 52
Effect of microgravity and environmental stress on brain energy metabolism and function 52
Modification of the skeletal muscle energy metabolism induced by intermittent normobaric hypoxia and treatment with biological pyrimidines 52
Parkinson-like disease by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in Macaca fascicularis: synaptosomal metabolism and action of dihydroergocriptine 51
Effect of microgravity and environmental stress on brain energy metabolism and function: human life support 51
Pharmacology of lazaroids and brain energy metabolism: a review 51
Bioenergetics of Desipramine: a Functional Proteomic Study 51
Decrease of rotenone inhibition is a sensitive parameter of complex I damage in brain non-synaptic mitochondria of aged rats 50
Factors involved in drug interference on enzyme activities of three mitochondrial populations from rat hippocampus 50
Cerebral endogenous substrate utilization during the recovery period after profound hypoglycemia 50
Functional proteomics of energy linked enzymes in lymphocytes is related to metabolic failure in acute stroke patients 50
Coenzyme Q homologs and vitamin E in synaptic and non-synaptic occipital cerebral cortex mitochondria in the ageing rat 49
Mitochondrial energy-linked enzymes in lymphocytes during ageing as biochemical markers for drug's action 49
The apolipoprotein(a) size polymorphism is assocated with Alzheimer's disease and vascular dementia 49
A critique on the preparation and enzymatic characterization of synaptic and nonsynaptic mitochondria from hippocampus 49
Action of L-acetylcarnitine on different cerebral mitochondrial populations from cerebral cortex 49
Age-related changes by hypoxia and TRH analogue on synaptic ATPase activities 49
Natural distribution and occurrence of coenzyme Q homologues 48
Functional proteomics of adenosine triphosphatase system in the rat striatum during aging 48
Modifications of synaptosomal plasma membrane protein composition in various brain regions during aging 48
Structural damage induced by peroxidation may account for functional impairment of heavy synaptic mitochondria 48
Energy metabolism of synaptosomal subpopulations from different neuronal systems of rat hippocampus: effect of L-acetylcarnitine administration in vivo 48
Coenzymes Q9 and Q10, vitamin E and peroxidation in rat synaptic and non-synaptic occipital cerebral cortex mitochondria during ageing 47
Synaptosomal non-mitochondrial ATPase activities and drug treatment 47
Energy-linked enzymes in lymphocytes of patients with a diagnosis of dementia 47
Mitochondrial and cytoplasmic enzymes of lymphocytes from patients with a diagnosis of dementia 47
Peripheral energy dysfunction in cerebral ischemia: focus on lymphocytes. 47
Cerebral cortex synaptic heavy mitochondria may represent the oldest synaptic mitochondrial population: biochemical heterogeneity and effects of L-acetylcarnitine 47
Effect of hypoxia and pharmacological treatment on some enzyme activities in dog brain areas 47
Effect of hypoxia on mitochondrial protein composition of cerebral cortex during aging 46
Mitochondrial Factors involved in Parkinson's Disease by MPTP toxicity in Macaca Fascicularis and drug effect 46
Aging and cerebral ischemia during postischemic recovery: enzyme activities of Krebs’ cycle, glutamate and related amino acids as a functional proteomics approach to evaluate the responsiveness of ischemic tissue and drug actions 46
Mitochondrial energy-linked enzymes in lymphocytes of patients with dementia 45
Parkinson-like disease by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity on energy-linked non-synaptic and intra-synaptic mitochondrial enzyme systems from Macaca fascicularis brain 45
Structural and functional aspects of the respiratory chain of synaptic and nonsynaptic mitochondria derived from selected brain regions 44
Enzyme mitochondrial systems during aging: pharmacological implications 44
Characterization of lymphocyte bioenergetics as potential biomarker in ischemic stroke patients during aging. 44
Coenzyme Q content in synaptic and non-synaptic mitochondria from different brain regions in the ageing rat 43
Synaptosomal non-mitochondrial ATPase activities: age-related alterations by chronic normobaric intermittent hypoxia 43
Bioenergetic effects of Clonidine on functional proteomics 43
Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria 43
Brain cytochrome oxidase activity of synaptic and nonsynaptic mitochondria during aging 42
Functional Proteomics and Metabolomics of Brain Energy Metabolism in Pathology and Therapy 42
Effect of in vivo administration of L-acetylcarnitine on ATP-ases of synaptic plasma membranes of rat striatum. 42
Energy metabolism of lymphocytes from acute stroke patients 42
Bioenergetics of lymphocytes as biomarkers of ischemic stroke patients during aging. 42
Modifications by chronic intermittent hypoxia and drug treatment on skeletal muscle metabolism 42
Differentiated effect of ageing on the enzymes of Krebs' cycle, electron transfer complexes and glutamate metabolism of non-synaptic and intra-synaptic mitochondria from cerebral cortex 41
Principi di farmacologia generale 41
Energy metabolism of rat cerebral cortex, hypothalamus and hypophysis during ageing. 41
Energetic state of aged brain during hypoxia 41
Recovery period after profound hypoglycemia. Influence of some metabolic modulators on the cerebral endogenous substrate utilization 40
Mitochondrial metabolism of lymphocytes during ageing 40
Bioenergetic characterization of lymphocytes from stroke patients. 40
Bioenergetic characterization of lymphocytes from stroke patients. 40
Lymphocytes bioenergetics after stroke: a functional proteomic study 38
Coenzyme Q, peroxidation and cytochrome oxidase features after parkinson's-like disease by MPTP toxicity in intra-synaptic and non-synaptic mitochondria from Macaca fascicularis cerebral cortex and hippocampus: action of dihydroergocriptine 38
Energy metabolism of mitochondria after ischemia and recovery times during aging and peripheral energy dysfunction in stroke patients: focus on lymphocytes 37
Effect of hypoxia on protein composition of synaptic plasma membranes from cerebral cortex during aging 37
Cerebral and cerebellar metabolic changes induced by drugs during the recovery period after profound hypoglycemia 36
Functional proteomics related to energy metabolism of synaptosomes from different neuronal systems of rat hippocampus during aging 36
The energy metabolism of cerebral mitochondria of hypertensive rats to study the action of drugs on this major risk factor for the prevention of ischaemic stroke. 35
Totale 5.155
Categoria #
all - tutte 21.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.255


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.634 492 675 8 72 1 85 7 80 13 143 50 8
2020/2021673 83 61 17 74 2 91 6 114 13 107 90 15
2021/2022463 13 1 7 5 5 8 12 35 30 7 76 264
2022/20231.578 191 92 6 101 176 173 0 112 652 10 43 22
2023/2024531 101 106 23 39 45 139 15 30 2 12 11 8
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 5.758